Development strategy of ENHERTU<sup>Ⓡ</sup>(trastuzumab deruxtecan)—anti-HER2 antibody–drug conjugate—Takashi Nakada, Norihiro Nishimoto, Ayako Arai, Daisuke KurokiDrug Delivery System(2021)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要